Skip to main content

Hayden Bird/Getty Images/iStockphoto

Brain scans of healthy people showed signs that the brain was shrinking in Alzheimer's-affected areas nearly a decade before the disease was diagnosed, U.S. researchers said on Wednesday.

The finding, published in the journal Neurology, may offer a new way to detect the disease early, an advance that could help in the development of effective treatments for Alzheimer's, a brain-wasting disease that affects up to 26 million people globally.

"The magnetic resonance measurements could be very important indicators to help identify who may be at risk of developing Alzheimer's dementia," Leyla deToledo-Morrell of Rush University Medical Center in Chicago, who worked on the study, said in a statement.

Story continues below advertisement

"If a drug therapy or treatment is developed in the future, those who are still without symptoms but at great risk would benefit the most from treatment," deToledo-Morrell said.

The study involved two groups of healthy people in their 70s who had brain scans at Rush University in Chicago and at Massachusetts General Hospital/Harvard Medical School in Boston and were followed for an average of nine years.

During the study, 50 participants remained cognitively normal and 15 developed Alzheimer's disease.

At the end of the study, people who had the highest amount of shrinkage in specific areas of the cerebral cortex were three times more likely to develop the disease.

"We also found that those who express this MRI marker of the Alzheimer's disease in the brain were three times more likely to develop dementia over the following 10 years than those with higher measurements," Dr. Brad Dickerson of Massachusetts General, who led the study, said in a statement.

"These are preliminary results that are not ready to be applied outside of research studies right now, but we are optimistic that this marker will be useful in the future," he said.

Researchers in the study used magnetic resonance imaging or MRI, equipment that is already in wide use in most hospitals.

Story continues below advertisement

Eli Lilly and Co, General Electric and other companies are developing special imaging agents that can detect proteins in the brain that signal the presence of Alzheimer's disease-related proteins.

But these tests currently are being developed to rule out Alzheimer's in patients who already have symptoms of the disease.



Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies